Logo image of NDLS

NOODLES & CO (NDLS) Stock Fundamental Analysis

NASDAQ:NDLS - Nasdaq - US65540B1052 - Common Stock - Currency: USD

1.46  -0.17 (-10.43%)

After market: 1.5297 +0.07 (+4.77%)

Fundamental Rating

1

Overall NDLS gets a fundamental rating of 1 out of 10. We evaluated NDLS against 135 industry peers in the Hotels, Restaurants & Leisure industry. Both the profitability and financial health of NDLS have multiple concerns. NDLS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year NDLS has reported negative net income.
NDLS had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: NDLS reported negative net income in multiple years.
In the past 5 years NDLS always reported a positive cash flow from operatings.
NDLS Yearly Net Income VS EBIT VS OCF VS FCFNDLS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M -60M

1.2 Ratios

NDLS has a Return On Assets of -9.59%. This is amonst the worse of the industry: NDLS underperforms 86.26% of its industry peers.
With a Return On Equity value of -874.35%, NDLS is not doing good in the industry: 69.47% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -9.59%
ROE -874.35%
ROIC N/A
ROA(3y)-0.85%
ROA(5y)-1.74%
ROE(3y)-11.68%
ROE(5y)-22.07%
ROIC(3y)N/A
ROIC(5y)N/A
NDLS Yearly ROA, ROE, ROICNDLS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150 -200 -250

1.3 Margins

In the last couple of years the Operating Margin of NDLS has declined.
With a Gross Margin value of 25.21%, NDLS is not doing good in the industry: 82.44% of the companies in the same industry are doing better.
NDLS's Gross Margin has been stable in the last couple of years.
NDLS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 25.21%
OM growth 3YN/A
OM growth 5Y-15.7%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.17%
GM growth 5Y-0.51%
NDLS Yearly Profit, Operating, Gross MarginsNDLS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20

0

2. Health

2.1 Basic Checks

NDLS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NDLS has less shares outstanding
The number of shares outstanding for NDLS has been increased compared to 5 years ago.
The debt/assets ratio for NDLS is higher compared to a year ago.
NDLS Yearly Shares OutstandingNDLS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
NDLS Yearly Total Debt VS Total AssetsNDLS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

Based on the Altman-Z score of 0.61, we must say that NDLS is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of NDLS (0.61) is worse than 74.81% of its industry peers.
A Debt/Equity ratio of 23.77 is on the high side and indicates that NDLS has dependencies on debt financing.
NDLS has a worse Debt to Equity ratio (23.77) than 69.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 23.77
Debt/FCF N/A
Altman-Z 0.61
ROIC/WACCN/A
WACC9.02%
NDLS Yearly LT Debt VS Equity VS FCFNDLS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 0.31 indicates that NDLS may have some problems paying its short term obligations.
NDLS has a worse Current ratio (0.31) than 90.08% of its industry peers.
NDLS has a Quick Ratio of 0.31. This is a bad value and indicates that NDLS is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.17, NDLS is not doing good in the industry: 97.71% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.31
Quick Ratio 0.17
NDLS Yearly Current Assets VS Current LiabilitesNDLS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

1

3. Growth

3.1 Past

NDLS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10664523917613334528.00%.
NDLS shows a decrease in Revenue. In the last year, the revenue decreased by -3.86%.
NDLS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.92% yearly.
EPS 1Y (TTM)-10664523917613335000%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-400%
Revenue 1Y (TTM)-3.86%
Revenue growth 3Y8.54%
Revenue growth 5Y1.92%
Sales Q2Q%-3.99%

3.2 Future

Based on estimates for the next years, NDLS will show a very negative growth in Earnings Per Share. The EPS will decrease by -52.10% on average per year.
The Revenue is expected to decrease by -0.28% on average over the next years.
EPS Next Y-338.6%
EPS Next 2Y-75.9%
EPS Next 3Y-52.1%
EPS Next 5YN/A
Revenue Next Year-1.88%
Revenue Next 2Y-1%
Revenue Next 3Y-0.28%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
NDLS Yearly Revenue VS EstimatesNDLS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
NDLS Yearly EPS VS EstimatesNDLS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 0.4 -0.4

1

4. Valuation

4.1 Price/Earnings Ratio

NDLS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NDLS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NDLS Price Earnings VS Forward Price EarningsNDLS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

89.31% of the companies in the same industry are more expensive than NDLS, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.67
NDLS Per share dataNDLS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

A cheap valuation may be justified as NDLS's earnings are expected to decrease with -52.10% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-75.9%
EPS Next 3Y-52.1%

0

5. Dividend

5.1 Amount

NDLS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NOODLES & CO

NASDAQ:NDLS (2/21/2025, 8:00:01 PM)

After market: 1.5297 +0.07 (+4.77%)

1.46

-0.17 (-10.43%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)03-06 2025-03-06/amc
Inst Owners37.91%
Inst Owner Change-97.4%
Ins Owners4.86%
Ins Owner Change0.43%
Market Cap66.69M
Analysts84.44
Price Target3.06 (109.59%)
Short Float %2.58%
Short Ratio2.8
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-49.76%
Min EPS beat(2)-107.6%
Max EPS beat(2)8.08%
EPS beat(4)2
Avg EPS beat(4)-164.83%
Min EPS beat(4)-586.27%
Max EPS beat(4)26.47%
EPS beat(8)5
Avg EPS beat(8)-30.57%
EPS beat(12)6
Avg EPS beat(12)-36.22%
EPS beat(16)7
Avg EPS beat(16)-53.28%
Revenue beat(2)0
Avg Revenue beat(2)-4.42%
Min Revenue beat(2)-4.47%
Max Revenue beat(2)-4.38%
Revenue beat(4)0
Avg Revenue beat(4)-3.39%
Min Revenue beat(4)-4.47%
Max Revenue beat(4)-1.97%
Revenue beat(8)0
Avg Revenue beat(8)-3.51%
Revenue beat(12)0
Avg Revenue beat(12)-3.25%
Revenue beat(16)1
Avg Revenue beat(16)-2.4%
PT rev (1m)0%
PT rev (3m)-14.29%
EPS NQ rev (1m)13.95%
EPS NQ rev (3m)7.5%
EPS NY rev (1m)5.15%
EPS NY rev (3m)-1.58%
Revenue NQ rev (1m)0.53%
Revenue NQ rev (3m)0.61%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)0.17%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.13
P/FCF N/A
P/OCF 3.77
P/B 17.86
P/tB N/A
EV/EBITDA 6.67
EPS(TTM)-0.37
EYN/A
EPS(NY)-0.31
Fwd EYN/A
FCF(TTM)-0.49
FCFYN/A
OCF(TTM)0.39
OCFY26.55%
SpS10.85
BVpS0.08
TBVpS-0.09
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.59%
ROE -874.35%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 25.21%
FCFM N/A
ROA(3y)-0.85%
ROA(5y)-1.74%
ROE(3y)-11.68%
ROE(5y)-22.07%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)2.46%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-15.7%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.17%
GM growth 5Y-0.51%
F-Score5
Asset Turnover1.46
Health
Industry RankSector Rank
Debt/Equity 23.77
Debt/FCF N/A
Debt/EBITDA 3.85
Cap/Depr 136.75%
Cap/Sales 8.13%
Interest Coverage N/A
Cash Conversion 76.76%
Profit Quality N/A
Current Ratio 0.31
Quick Ratio 0.17
Altman-Z 0.61
F-Score5
WACC9.02%
ROIC/WACCN/A
Cap/Depr(3y)141.33%
Cap/Depr(5y)111.4%
Cap/Sales(3y)6.98%
Cap/Sales(5y)5.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10664523917613335000%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-400%
EPS Next Y-338.6%
EPS Next 2Y-75.9%
EPS Next 3Y-52.1%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.86%
Revenue growth 3Y8.54%
Revenue growth 5Y1.92%
Sales Q2Q%-3.99%
Revenue Next Year-1.88%
Revenue Next 2Y-1%
Revenue Next 3Y-0.28%
Revenue Next 5YN/A
EBIT growth 1Y-183.05%
EBIT growth 3YN/A
EBIT growth 5Y-14.08%
EBIT Next Year290.57%
EBIT Next 3Y66.04%
EBIT Next 5YN/A
FCF growth 1Y-58.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y25.69%
OCF growth 3Y44.46%
OCF growth 5Y38.73%